Company / Book Value per Share
NovoCure Ltd Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.137
FY2025
5-year range
$2.128 / $4.583
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
#128 of 158
Health Care
What the data says
NovoCure Ltd's book value per share of $3.137 is lower than 81% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $4.583 in FY2022 to $3.137 in FY2025.
Based on SEC 10-K filings.
$3.137 in FY2025 with a 5-year CAGR of +22.7%.
Declined from $3.451 to $3.137 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- +22.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 158This company $3.137 Sector average $48.072
▼
-93.5% below sector average
Key checks
Key Insights
- NovoCure Ltd's book value per share has declined for 3 consecutive years.
- 5-year CAGR of +22.7%, indicating consistent growth.
- In FY2025, book value per share decreased 6.7% year-over-year.
- Ranks #128 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.137 | -6.7% |
| FY2024 | $3.364 | -2.5% |
| FY2023 | $3.451 | -24.7% |
| FY2022 | $4.583 | +115.4% |
| FY2021 | $2.128 | +88.7% |
| FY2020 | $1.128 | -7.4% |
| FY2019 | $1.218 | -23.4% |
| FY2018 | $1.591 | -44.8% |
| FY2017 | $2.881 | +146.6% |
| FY2016 | $1.168 | -90.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026